New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape

September 15, 2010

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …

New Commercial Realities – Part 1: Key drivers of the evolving pharmaceutical landscape

September 15, 2010

Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …

Boehringer Ingelheim Facebook picture

Digital Pharma: Boehringer gets social with Facebook

September 14, 2010
Medical Communications Boehringer, Digital Pharma blog, Facebook

Boehringer Ingelheim is looking for fans on Facebook and wants its employees to be thought of as “superheroes, only with …

Positive results for irritable bowel syndrome drug

September 14, 2010
Research and Development Almirall, IBS, linaclotide

A new treatment for patients with irritable bowel syndrome with constipation has produced promising results in a phase III trial. …

iPhone app is download hit for Doctors.net.uk

September 14, 2010
Medical Communications Doctors.net.uk, doctors, iphone, tala, tim ringrose

An app launched by Doctors.net.uk in response to a surge in the number of doctors signing up for iPhones, has …

Future of Roche diabetes trial uncertain

September 14, 2010
Research and Development GLP-1, Roche, taspoglutide

Roche has admitted it does not know when phase III trials of the investigational type II diabetes drug taspoglutide will …

Growth slowdown predicted for pharma packaging

September 14, 2010
Manufacturing and Production packaging, pharma packaging

New regulatory requirements in the US are driving growth in the country’s pharmaceutical packaging market, according to market research firm …

Novasep appoints new supervisory board chairman

September 14, 2010
Manufacturing and Production Novasep, appointment, manufacturing and production

French contract manufacturing firm Novasep has appointed Bernard Dubois to its top management team. Most recently a consultant, Bernard formerly …

Genzyme planning 1,000 job cuts

September 14, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, job cuts

Genzyme has said it intends to cut back its workforce by around 1,000 over the next 15 months in order …

GSK launches global joint pain education programme

September 13, 2010
Medical Communications chronic pain, disease awareness campaigns, osteoarthritis

GlaxoSmithKline has launched a global education programme to help sufferers from musculoskeletal conditions such as arthritis to self-manage pain in …

Zactima extends progression free survival in other thyroid cancers

September 13, 2010
Research and Development thyroid cancer, zactima

New data suggests patients with the more common forms of thyroid cancer respond to AstraZeneca’s Zactima. The drug has already …

NICE won’t approve Abilify without more data

September 13, 2010
Sales and Marketing Abilify, BMS, NICE

NICE is unlikely to approve Bristol-Myers Squibb’s schizophrenia drug Abilify unless the company can provide more data on its clinical …

Countdown to Launch

September 13, 2010
Sales and Marketing marketing, product launch

When NASA launches a rocket, most of the hard work is already done. The flight itself is relatively short, yet …

Patrick_Hopkinson

BMS appoints UK market access director

September 13, 2010
Sales and Marketing BMS, UK, appointment, sales and marketing

Patrick Hopkinson has joined Bristol-Myers Squibb as director of market access and external affairs in the UK. He joins the …

AZ signs cancer development deal

September 13, 2010
Research and Development AstraZeneca, CRT, Cancer Research UK

AstraZeneca has agreed a deal with charity Cancer Research UK to develop a first-in-class cancer treatment. AZD-3965 targets the monocarboxylate …

Sanofi readies cancer drugs’ coms support

September 10, 2010
Medical Communications just health pr

Sanofi-Aventis is readying communications support for two cancer drugs in its portfolio. The pharma company has handed UK communications for …

Merck plans jobs cuts in Ireland

September 10, 2010
Manufacturing and Production Ireland, Merck & Co, Schering-Plough, job cuts

A manufacturing plant in Ireland is the latest to face staff cuts in the wake of Merck & Co’s merger …

Transgene acquires rights to cancer vaccine

September 10, 2010
Research and Development JX-594, Jennerex, Transgene, cancer vaccine

French biotech company Transgene has acquired rights to commercialise a novel cancer vaccine that is being tested against multiple types …

Novo Nordisk's Victoza

Low dose Victoza on track for NICE approval

September 10, 2010
Sales and Marketing NICE, Novo Nordisk, Victoza

Novo Nordisk is on track to receive NICE approval for its type II diabetes drug Victoza, but will still have …

Adventis Health adds new recruits

September 10, 2010
Medical Communications Adventis, appointment, medical communications

Beaconsfield, UK-based healthcare communications agency Adventis Health has added two more recruits to its multi-disciplinary teams. Dan Blomfield (pictured left), …

The Gateway to Local Adoption Series

Latest content